Cisapride Improves Enteral Tolerance in Pediatric Short-bowel Syndrome With Dysmotility
نویسندگان
چکیده
منابع مشابه
Enteral nutrition as primary therapy in short bowel syndrome.
The spectacular success of parenteral nutrition in supporting patients during small intestinal adaptation after massive resection, tends to obscure the prolonged periods often needed for such adaptation to take place. After neonatal small intestinal resection for example, it may take more than five years before adaptation is complete. There is therefore a strong argument for examining ways in w...
متن کاملOverview of pediatric short bowel syndrome.
Short bowel syndrome (SBS) is a malabsorptive state occuring as a result of surgical resection or congenital disease of a significant portion of the small intestine . The amount of resection or remaining bowel generally dictates the degree of malabsorption and consequentely the need for specialized enteral nutrition or parenteral nutrition (PN). Intestinal failure in the context of SBS is defin...
متن کاملNutritional Management of Pediatric Short Bowel Syndrome
Ana Abad-Sinden, MS, RD, CNSD, Director, Dietetic Internship Program, Pediatric Nutrition Support Specialist and James Sutphen, M.D., Assistant Professor, UVA Health System, Department of Nutrition Services, Charlottesville, VA. Pediatric short bowel syndrome (SBS), usually caused by massive intestinal resection, presents a significant nutritional challenge to the pediatric clinician. The overa...
متن کاملSerial transverse enteroplasty to facilitate enteral autonomy in selected children with short bowel syndrome
BACKGROUND Serial transverse enteroplasty (STEP) was first described in 2003 as a method for lengthening and tapering of the bowel in short bowel syndrome. The aim of this multicentre study was to review the outcome of a Swedish cohort of children who underwent STEP. METHODS All children who had a STEP procedure at one of the four centres of paediatric surgery in Sweden between September 2005...
متن کاملIGF-I treatment facilitates transition from parenteral to enteral nutrition in rats with short bowel syndrome.
The goal of growth factor treatment in patients with short bowel syndrome (SBS) is to facilitate transition from parenteral to enteral feedings. Ideal use of growth factors would be acute treatment that produces sustained effects. We investigated the ability of acute insulin-like growth factor I (IGF-I) treatment to facilitate weaning from total parenteral nutrition (TPN) to enteral feeding in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Pediatric Gastroenterology & Nutrition
سال: 2011
ISSN: 0277-2116
DOI: 10.1097/mpg.0b013e3181fe2d7a